XML 43 R36.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders' Equity - Additional Information (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 05, 2024
USD ($)
May 31, 2024
USD ($)
shares
Jan. 31, 2024
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
Installment
Director
$ / shares
shares
Jun. 30, 2023
USD ($)
$ / shares
Dec. 31, 2023
shares
Nov. 30, 2021
USD ($)
Stock based compensation expense reversal                  
Members of the Company's board of directors | Director           2      
Common stock, shares issued | shares       100,119,518   100,119,518   61,468,743  
Net proceeds from issuance of common stock           $ 97,871 $ 52,370    
Weighted-average grant date fair value of options granted | $ / shares           $ 17.04 $ 7.93    
Stock-based compensation expense       $ 6,736 $ 4,749 $ 26,642 $ 9,366    
Intrinsic value of options exercised           $ 45,400 $ 7,000    
Common Stock [Member]                  
Stock based compensation expense reversal                  
Common stock, shares issued | shares   12,075,000 19,722,500 3,800,465   3,800,465      
Net proceeds from issuance of common stock   $ 351,300 $ 323,900     $ 97,900      
Sale price per share | $ / shares       $ 26.86   $ 26.86      
Common Stock [Member] | Forbion and related affiliated entities                  
Stock based compensation expense reversal                  
Common stock, shares issued | shares     1,714,285            
Sale price per share | $ / shares     $ 17.5            
Aggregate gross proceeds     $ 30,000            
Forbion [Member]                  
Stock based compensation expense reversal                  
Subsidiary, Ownership Percentage, Noncontrolling Owner       5.00%   5.00%      
Stock Option                  
Stock based compensation expense reversal                  
Unrecognized compensation expense       $ 37,400   $ 37,400      
Unrecognized share based compensation expense, recognition period           2 years 7 months 6 days      
Stock-based compensation expense           $ 3,200      
Stock Option | Separation and Consulting Agreements [Member]                  
Stock based compensation expense reversal                  
Stock option awards, forfeited | shares           223,533      
Restricted Stock Units ("RSUs")                  
Stock based compensation expense reversal                  
Unrecognized compensation expense       $ 27,300   $ 27,300      
Unrecognized share based compensation expense, recognition period           3 years      
Stock-based compensation expense           $ 10,500      
Number of share of common stock receivable upon vesting | shares           1      
2024 ATM Prospectus | Common Stock [Member]                  
Stock based compensation expense reversal                  
Sale of Stock, Consideration Received Per Transaction $ 200,000                
Market Offering [Member] | Common Stock [Member]                  
Stock based compensation expense reversal                  
Common stock aggregate offer price                 $ 150,000
2020 Plan                  
Stock based compensation expense reversal                  
Number of shares available for future issuance | shares       4,894,073   4,894,073      
2020 Plan | Restricted Stock Units ("RSUs")                  
Stock based compensation expense reversal                  
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights           The Company grants RSUs with service conditions that vest in four equal annual installments provided that the employee remains employed with the Company, RSUs with service conditions that vest in sixteen equal quarterly installments provided that the employee remains employed with the Company and RSUs with performance-based vesting conditions. As of June 30, 2024, there are no RSUs with performance-based vesting conditions outstanding.      
Share-based Compensation Arrangement By Share-based Payment Award Grant Service Conditions to Vest Number of Annual Installments | Installment           4      
2024Plan                  
Stock based compensation expense reversal                  
Number of shares available for future issuance | shares       220,147   220,147      
2024Plan | Common Stock [Member]                  
Stock based compensation expense reversal                  
Number of shares granted | shares           900,000